Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Recruiting 5Completed 3Active not recruiting 3Withdrawn 2Unknown 2Terminated 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3

Conditions

Breast Neoplasms 315Lymphoma 282Leukemia 227Precursor Cell Lymphoblastic Leukemia-Lymphoma 216Lymphoma, Non-Hodgkin 178Leukemia, Lymphocytic, Chronic, B-Cell 177Multiple Myeloma 174Lymphoma, Large B-Cell, Diffuse 174Lymphoma, Follicular 142Leukemia, Myeloid, Acute 136Lymphoma, Mantle-Cell 126Hodgkin Disease 125Burkitt Lymphoma 118Myelodysplastic Syndromes 110Lymphoma, Large-Cell, Immunoblastic 89Lymphoma, B-Cell, Marginal Zone 85Recurrence 67Neoplasms, Plasma Cell 62Leukemia, Myeloid, Chronic-Phase 59Neuroblastoma 56Dendritic Cell Sarcoma, Interdigitating 56Leukemia, Myeloid, Accelerated Phase 55Myeloproliferative Disorders 54Melanoma 54Congenital Abnormalities 48Neoplasms 47Leukemia, Myelomonocytic, Chronic 45Leukemia, Myelogenous, Chronic, BCR-ABL Positive 45Blast Crisis 45Lymphoma, Large-Cell, Anaplastic 44

Interventions

Doxorubicin 11Ifosfamide 9Radiotherapy 6tazemetostat 4pegfilgrastim 3cixutumumab 3Imatinib Mesylate 3Filgrastim 3Cyclophosphamide 3pazopanib 2Trabectedin 2Sunitinib 2Sorafenib 2Etoposide 2Dacarbazine 2Chemotherapy, Adjuvant 2trofosfamide 1tremelimumab 1temsirolimus 1soblidotin 1sargramostim 1romidepsin 1ribociclib 1reolysin 1poly ICLC 1perifosine 1pembrolizumab 1lorvotuzumab mertansine 1liposomal doxorubicin 1ixabepilone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Sarcoma, Synovial × Cyclophosphamide × Clear all
NCT03250325 2024-11-20

Study of TBI-1301 (NY-ESO-1 T Cell Receptor Gene Transduced Autologous T Lymphocytes) in Patients with Synovial Sarcoma

Takara Bio Inc.

Phase 1/2 Completed
8 enrolled
Sarcoma

Sarcoma, Synovial

NCT03450122 2023-10-16

Modified T Cells, Chemotherapy, and Aldesleukin With or Without LV305 and CMB305 in Treating Participants With Advanced or Recurrent Sarcoma

M.D. Anderson Cancer Center

Phase 1 Completed
15 enrolled
Sarcoma

Sarcoma, Synovial, Liposarcoma, Myxoid

NCT01477021 2014-12-11

Autologous T Cells and Cyclophosphamide in Treating Patients With Soft Tissue Sarcoma That is Metastatic or Cannot Be Removed By Surgery

Fred Hutchinson Cancer Center

Phase 1 Completed
6 enrolled
Sarcoma

Liposarcoma, Sarcoma, Sarcoma, Synovial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡